ERTUGLIFLOZIN (Steglatro®)
Clinical Indication
Type 2 diabetes mellitus (for 18 years and over) as monotherapy
Comments
In line with NICE TA 572
Conditional on prescriber being competent to select appropriate patients
Date of classification
June 2019
Green
Medicines which could be started in any health care setting and do not require oversight by a specialist and which primary care would have full responsibility for prescribing and monitoring.